Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea
Status:
Recruiting
Trial end date:
2022-07-31
Target enrollment:
Participant gender:
Summary
This study will compare treatment outcome with pulsed dye laser, when used used as an
adjunctive treatment to oxymetazoline HCl 1% cream, compared to oxymetazoline HCL 1% cream
alone, for patients with moderate or severe erythematotelangiectatic rosacea.